Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development

Mónika Z. Ballmann, Svjetlana Raus, Ruben Engelhart, Győző L. Kaján, Abdelaziz Beqqali, Patrick Wf Hadoke, Chantal Van Der Zalm, Tibor Papp, Lijo John, Selina Khan, Satish Boedhoe, Katarina Danskog, Lars Frängsmyr, Jerome Custers, Wilfried A.m. Bakker, Hilde M. Van Der Schaar, Niklas Arnberg, Angelique A.c. Lemckert, Menzo Havenga, Andrew H. Baker^*

^*Corresponding author for this work